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ABSTRACT
MODULATION OF DISEASE IN AN ANIMAL MODEL OF MULTIPLE SCLEROSIS
SEPTEMBER 2016
MANIT MUNSHI, B.S., UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Barbara Osborne

Multiple Sclerosis (MS) is a neurodegenerative autoimmune disease that affects millions
of people worldwide. Although the exact cause of MS is unknown, it is clear that CD4+ T helper
cells play a significant role, namely T helper 1 (Th1) and T helper 17 (Th17) cells. The Notch
family of proteins plays a role in the development and differentiation of T helper cells. Previous
data has shown that inhibition of Notch impairs the ability of T helper cell differentiation.
Additionally specific inhibition of certain Notch members inhibits specific T helper cell
differentiation, for example the inhibition of Notch 1 inhibits Th1 and iTreg polarization [Samon
et al., 2008]. However, the effects of the other Notch family members on CD4+ T cells are not
fully studied. We propose that Notch 3 plays an extensive role in the regulation of Th1, Th2,
Th17, and iTreg polarizations. In addition, we propose that Notch 3 regulates function of T
helper cell function in the mouse model of MS, experimental autoimmune encephalomyelitis
(EAE). Data in this thesis show that Notch 3 plays a significant role in the polarization of Th1,
Th17 and iTreg polarization [Karlsson et al., 2011]. We present evidence that the heterozygous
and homozygous Notch 3 knockout exhibits a significant decrease in polarization toward Th1,
Th17 and iTreg cell fates.
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Exopolysaccharide (EPS) is a compound that has been previously shown to play a
protective role in other inflammatory diseases. EPS has been shown to produce antiinflammatory macrophages. We propose that a similar anti-inflammatory effect might be
possible in EAE. We found that EPS had a significant effect on EAE induction, decreasing the
onset and peak disease score. EPS also reduced the concentration of IFN-γ, IL17A, and GM-CSF
in the supernatants of the splenocytes after restimulation with MOG. Further experimental
data is needed to prove the effects of EPS on EAE and the method by which EPS function. These
data indicate that Notch 3 could be crucial in regards to EAE due to the effects on Th1 and Th17
which are instrumental in EAE induction [Raphael et al., 2015].
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CHAPTER 1
INTRODUCTION

1.1. CD4+ T cell development and function
The human immune system can be divided into two distinct arms, the innate and the
adaptive immune system. The innate immune system is comprised of cells and mechanisms
that are responsible for immediate defense against infection. However the adaptive immune
system is a complex system of cells designed to react against specific pathogens and create a
memory against that pathogen for future repeated exposures. The adaptive immune system is
comprised of many cell types including B cells and T cells, of which there are two kinds; CD8+ T
cells are responsible for inducing the death of damaged, infected or dysfunctional cells, while
CD4+ T cells are a subset of lymphocytes which are responsible for helping or suppressing and
regulating the immune system [Radtke et al., 2013].
CD4+ T cells, also known as T helper cells, are crucial for a targeted immune response. As
all T cells, T helper cells originate from the bone marrow as lymphoid progenitor cells. From
there, they migrate to the thymus and expand creating a population of T-cell precursors. These
precursors go through multiple processes such as beta selection, positive selection, and
negative selection, which results in the production of T cells that have a functional T cell
receptor (TCR) capable of recognizing and binding to peptides without binding strongly to selfantigens. These cells then migrate to the spleen where they can be activated by antigen
presenting cells (APCs). This is done by the MHC class II molecules on APCs in addition to a costimulatory signal by B7 through the TCR and CD28 receptor on the T cell respectively. These
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two signals, accompanied by certain cytokines, result in the differentiation and proliferation of
a specific T helper cells. These cells are Th1, Th2, Th17, Treg as well as other, less researched,
subtypes. These T helper cells not only range in the cytokines they are able to produce but also
the surface markers they express as well as being capable of re-differentiating into other T
helper subtypes [Mitchell et al., 2001].

1.2. Th1 cell development and function
T helper 1 (Th1) cells play an important role in the defense of intracellular pathogens.
Th1 cells produce IL-2, IL-10, interferon-gamma (IFN-γ) and Tumor Necrosis Factor-alpha (TNFα) [Asseman et al., 1999]. Th1 cells are driven by the transcription factors T-bet and STAT-4, as
well as STAT-1 and STAT-5 [Grifka-Walk et al., 2013, Zhou et al., 2009]. IFN-y producing Th1 cells
are important for CD8+ T cell activation via MHC class II molecules as well as for activation of
macrophages. IL-2 is a key cytokine for the proliferation of T cells and B cells. It also plays an
important role in T cell memory. IL-10 acts as a negative feedback loop, suppressing excessive
Th1 activity [Asseman et al., 1999].
With IFN-γ producing cells being found in the central nervous system (CNS) of MS
patients, Th1 cells are thought to one of the more prominent inducers of MS. Along with Th17
cells, Th1 cells are responsible for the inflammation as well as the degeneration of neurons in
the CNS [Jager et al., 2009]. Th1 cells are therefore another primary target of MS therapy along
with Th17 cells. Although thought to have a prominent role due to the presence of T-bet and
IFN-γ in the CNS of MS patients, the neutralization of IFN-γ does not result in a reduction in MS
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score while inhibition of T-bet results in both a decrease in Th1 and Th17 induction and
improves EAE in mice [Grifka-Walk et al., 2013, Jager et al., 2009].

1.3. Th2 cell development and function
T helper 2 (Th2) cells are important in the defense against extracellular parasites as well
as play a role in allergies. Th2 cells are known for the production of the IL-4, IL-5, IL-9, IL-10, IL13, and IL-25 cytokines [Zhu et al., 2001]. The key transcription factor for Th2 cells is GATA-3 in
addition to other factors such as STAT6. These transcriptions factors play an important role in T
cell development and the promotion and selection of the previously mentioned cytokines. Th2
cells are known to associate with B-cells, eosinophils and mast cells [Zhu et al., 2001]. Through
IL-5, IL-9, Th2 cells promote the activation of these cells. IL-4 has many roles, including an effect
on B cells resulting in class switching to produce IgE antibodies, as a positive feedback for Th2
cell differentiation, and possibly in the activation of macrophages against parasites [Cote-Sierra
et al. 2004]. IL-10 is thought to play a role as a suppressor of Th1 differentiation and activity,
thereby promoting increased Th2 differentiation. In addition to IL-4, IL-2 also plays an
important role in Th2 differentiation [Cote-Sierra et al. 2004].
In Multiple Sclerosis (MS), Th2 cells are thought to be involved through B cells by the
promotion of antibody production and class switching which can result in autoimmunity.
However, Th2 cells are also thought to inhibit macrophages and suppress inflammatory
cytokines, such as those produced by Th1 and Th17 cells, which are thought to be directly
involved in MS induction [Sun et al., 2008]. It is therefore difficult to determine whether Th2

3

cells are involved positively in disease by the direct suppression of inflammatory cells or
whether they are involved negatively by the induction of antibody mediated autoimmunity.

1.4. Th17 cell development and function
T helper 17 (Th17) cells are important in the defense against extracellular bacteria and
fungi. Primary cytokines of Th17 cells include IL-17A, IL-17F, IL-21 and IL-22 [Ivanov et al., 2007].
Th17 cell transcription factors include STAT-3 and retinoic acid receptor related orphan
receptor gamma T (RORyT) [Ivanov et al. 2006, 16]. Th17 cell polarization can be induced in the
presence of IL-6, IL-21, IL-23 and TGFβ [Mangan et al., 2006, Zhou et al., 2007, Zhou et al.,
2008]. IL-17 is a pro-inflammatory cytokine which can cause the production of multiple other
cytokines, including IL-6, GM-CSF, and TNF-α, as well as the chemokine CXCL-8 [Sheng et al.,
2014]. In addition, IL-17A and IL-17F are capable of recruiting and activating neutrophils, which
are essential for the bacterial and fungal immune responses. IL-21 acts as a positive feedback
loop, to further amplify Th17 polarization as well as activate dendritic cells (DCs), CD8 + T cells, B
cells, and natural killer (NK) cells [Zhou et al., 2007].
Th17 cells are thought to be a contributing factor to the inflammatory profile of the CNS
in MS patients [Grifka-Walk et al., 2013]. IL-23 generated Th17 cells are very prominent in the
development of MS and neutralization of IL-17 has shown a dramatic decrease in the severity of
MS induction in mice [Manel et al., 2008]. In addition to Th1 cells, the pro-inflammatory
abilities and neutrophil recruitment capability of Th17 cells are key reasons why they are
thought to be a critical target in MS treatment.
4

1.5. Treg cell development and function
T regulatory (Treg) cells, as the name would suggest, are responsible for the regulation
of the immune system, as well as protecting against autoimmune disease and reactivity
towards self-antigens. There are two types of Treg cells, natural Treg (nTreg) and induced Treg
(iTreg) [Curotto de Lafaille et al., 2009]. Treg cells that developed in the thymus are known as
nTregs, while those that differentiate in the lymph nodes and are induced by cytokines are
iTregs [Liu et al., 2008]. iTreg cells can be induced both in vivo outside of the thyus as well as in
vitro, however nTreg cells can only be produced inside the thymus in vivo. Treg cells produce
the anti-inflammatory cytokines transforming growth factor β (TGFβ), IL-10, and IL-35 [Curotto
de Lafaille et al., 2009]. Treg cells express the Foxp3 transcription factor as well as STAT-5
[Fontenot et al., 2003]. The production of TGFβ allows Treg cells to both produce more iTregs as
well as act as a suppressive cytokine [Li et al., 2007]. IL-10 is an anti-inflammatory cytokine and
IL-35 acts as an immune suppressor [Asseman et al., 1999]. These cytokines help build the
suppressive and regulatory profile of Treg cells in vitro [Karlsson et al., 2011]. iTreg cell
polarization has been shown to be regulated by Notch 1 but could also be regulated by another
Notch family member [Palaga et al., 2003, Samon et al., 2008].
Relating to MS, Treg cells are very important in reducing inflammation and reinforcing
tolerance of immune cells towards self antigens. The neurodegenerative effects of Th1 and
Th17 cells thought to be responsible for the symptoms of MS may be counteracted as well as
possibly prevented by Treg induction [Karlsson et al., 2011]. However, as a drawback, the
suppressive effect of Treg cells on autoimmunity, without control, could lead to oversuppression of the immune system.
5

1.6. Multiple Sclerosis
Multiple sclerosis (MS) is an autoimmune disease that afflicts millions of people
worldwide. Many risk factors exist which can make a person more susceptible to develop MS,
including gender, race, life style, dietary and environmental factors, however the initial events
that can cause development to occur are yet unknown. Certain genetic risk factors also exist,
including polymorphism in MHC class II molecules as well as the IL-2 receptor α chain, both of
which are important receptors in T cell development. Although not fatal, the disease is
characterized by inflammation of the central nervous system and destruction of myelin sheaths
of neurons, as well as oligodendrocytes responsible for re-myelination (Figure 2)[Jurynczyk et
al., 2008]. In this way, this debilitating disease causes muscle weakness, muscle spasms,
difficulty moving, ataxia, and many other neurological symptoms [Jurynczyk et al., 2010]. Early
on, the lymphocytes responsible for MS breach the blood-brain barrier, forming lesions called
plaques. These plaques contain CD4+ and CD8+ lymphocytes and macrophages, which destroy
myelin. During late stage of MS, the plaques are reduced to demyelinated or destroyed axons
and scar tissue, which can prevent remyelination or recovery [Jurynczyk et al., 2005].
Experimental Autoimmune Encephalomyelitis (EAE) is the most commonly used mouse
model for MS in research. It mimics many of the neurological and muscular symptoms however
over a quicker time course. The one drawback is that EAE can be fatal. Studies in EAE have
revealed the critical role that CD4+ T cells play in MS induction. From neutralization of specific
CD4+ T cells to the adoptive transfer of T cell immunized with EAE specific peptides, the role of
various CD4+ T cells have been identified and analyzed. Although not completely understood,
6

data have shown that various CD4+ T cell cytokines play a significant role in MS development
[Jurynczyk et al., 2005]. Specifically, it is known that both Th1 and Th17 cells play a role in MS
induction, although the exact role that those cells play is not completely clear due to the
paradoxical nature of Th1 involvement [Jager et al., 2009, Stoolman et al., 2014]. Data has
shown that both reducing IFN-γ as well as overexpressing INF-γ results in exacerbated EAE
severity [Raphael et al., 2015]. Th17 cells are shown to play a role by the blockage of IL17
resulting in reduced EAE severity [Raphael et al., 2015]. These reports seem to point to either
an undefined relationship between Th1 and Th17 cells in the induction of EAE, or another
indirect pathway through a different cell type. Another important consideration is the presence
of the cytokine granulocyte-monocyte colony stimulating factor (GM-CSF), which is crucial in
the maturation of monocytes into macrophages and the activation of those macrophages
[Raphael et al., 2015, Sheng et al., 2014]. It is shown that reduction of GM-CSF in mice can lead
to reduced EAE severity, even with similar IFN-γ and IL-17A production as normal WT mice
[Sheng et al., 2014]. Therefore it is important to consider not only the cytokines that play a
pivotal role in the disease, but also the cells which produce these cytokines since they provide
multiple targets for therapy.

1.7. Notch signaling
Notch is a protein receptor that initiates key signaling pathways. It has previously been
shown to be essential in development as well as play a significant role in various diseases,
including modulation of MS [Arboleda-Velasquez et al., 2008]. There are four different isoforms
of Notch (1-4), which vary in the number of EGF repeats in the extracellular region, the
7

possession of a trans-activation domain, the number of nuclear localization signal domains and
the transcriptional targets (Figure 1). Notch signaling occurs when a ligand, either Delta-like 1-4
or Jagged 1-2, on the surface of another cell interacts with Notch. This results in an initial
extracellular cleavage by an ADAM protease followed by a transmembrane cleavage by gamma
secretase [Radtke et al., 2010]. Once free of the membrane, the intracellular domain of Notch
is able to translocate to the nucleus where it is able to interact with RBPJk/CSL, removing the
transcriptional repressor and initiating the activation of other targets [Palaga et al., 2003,
Radtke et al., 2013, Tsukomo et al., 2004]. This process, known as canonical Notch signaling, is
not the only process by which Notch signaling occurs. Another process by which Notch
activation occurs, termed non-canonical Notch signaling, is less well characterized.
Notch signaling plays a crucial role in the development of T helper cells [Palaga et al.,
2003, Radtke et al., 2004]. For example, T helper cells can be polarized toward Th1 by the
overexpression of the Notch 1 as well as the Notch 3 isoform, or by the activation of the cell by
the Delta-like ligand 1 (DLL1) [Palaga et al., 2003, Radtke et al., 2004]. In addition, it has been
shown that the reduction of Notch signaling by gamma secretase inhibition, results in reduced
Th1 polarization [Palaga et al., 2003]. Similarly, Jagged 1 signaling of T helper cells increases the
polarization towards Th2 cells, as well as overexpression of Notch 1 or Notch 2 [Radtke et al.,
2010, Radtke et al., 2004]. It is also suggested in a recent study by our group that Notch 1 plays
an important role in Treg polarization [Palaga et al., 2003, Samon et al., 2008]. Due to effect of
Notch on the polarization of T helper cells, and the effect of these cells in MS, it is possible that
Notch could be a target for MS therapy. It has been shown that the using gamma secretase
inhibitors decreased EAE scores compared to control groups [Jurynczyk et al., 2008]. In
8

addition, it has been shown that antibody-blocked Notch 1 has no effect on EAE scores and that
a Notch 3 blocking antibody lessens EAE severity [Jurynczyk et al., 2010]. Although the
authentication of the effectiveness and precision of these antibodies is unclear, these data
suggest that Notch 3 may be an effective target for a new method of EAE therapy. In addition, a
variety of Notch ligands have been shown to have effects on EAE severity, both being shown to
ameliorate (DLL1 and DLL4) and exacerbate (Jagged 1) disease [Arboleda-Velasquez et al.,
2008].

1.8. Exopolysaccharide
Through collaboration with Katherine L. Knight of Loyola University in Chicago, it has
been determined that Exopolysaccharide (EPS) could play an important role in EAE suppression
[Jones et al., 2014]. EPS is a secreted polysaccharide that has been shown to play a role in
protection against intestinal inflammation. As EAE is an inflammatory disease of the CNS, we
hypothesized that there could be a role for inflammation suppression of EPS in EAE. EPS is
composed primarily of carbohydrates, namely mannose and glucose.
Using the inflammatory pathogen Citrobacter rodentium as a model for colitis, the
Knight lab showed that the bacterium, Bacillus subtilis, protects mice from C. rodentium [Jones
et al., 2014]. It was shown that no symptoms, including diarrhea, cytokine levels, and changes
in colonic architecture, were present with mice that were treated with B. subtilis. In a previous
study, Knight showed that EPS mutant B. subtilis failed to prevent disease from C. rodentium.
Using EPS overexpressing strain of B. subtilis, it was shown that EPS was, by itself, sufficient
enough to abrogate disease. In addition to showing the anti-inflammatory effects of EPS, they
9

also looked at the pathways through which EPS may work specifically focusing on the MyD88
pathways and Toll-like receptors (TLRs). Looking at MyD88, they were able to determine that
MyD88 knock out mice displayed severe disease scores and the use of B. subtilis was
ineffective. This showed a clear role for MyD88 in EPS-mediated prevention of colitis. To see
which MyD88-dependent TLR was needed for protection against colitis, they looked at different
TLR knockouts, (TLR4 and TLR2 specifically). They showed that when TLR4 was knockout out,
disease was not prevented in the presence of EPS. However, they also showed that using just a
TLR4 agonist does not have the same result on colitis protection. This data proves that EPS does
affect TLR4 through MyD88.
Finally the Knight lab examined cells which bind to EPS [Jones et al., 2014]. EPS was
injected peritoneally and it was observed that almost all the EPS was bound to peritoneal
F4/80+ CD11b+ macrophages. In addition, they found that EPS bound to these peritoneal
macrophages even in TLR4 knock-out mice, showing that EPS does not rely on TLR4 to bind to
the macrophages and may bind to another receptor. In order to show the effects on cytokines
related to colitis, the group incubated TLR4 knock-out and WT cells with EPS and observed no
difference. In addition, they looked at the effects of TLR4 agonist (LPS) and a TLR2 agonist
(Pam3Cys4) and also on WT and TLR4KO and noticed that no difference in the knock out cells,
while WT cells expressed various inflammatory cytokines in response to LPS and Pam3Cys4.
This experiment concluded that EPS requires TLR4 signaling, but may not bind directly to TLR4.
In addition, EPS does not produce or directly cause the production of pro-inflammatory
cytokines.
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The Knight lab then looked at the effects of EPS on epithelial cells versus myeloid cells
and noticed that there was no change, if not an increase, in disease score in myeloid knock out
mice versus the expected decrease in disease in epithelial knock out mice [Jones et al., 2014].
Finally they looked at the ability of EPS protection to transfer from one mouse to another by
adoptive transfer. In these experiments, they found that not only does the protective ability
transfer, but it transfers from WT mice to TLR4 knock-out mice as well. In addition, it does not
transfer from TLR4 knock-out mice to WT. They showed that epithelial myeloid cells require
TLR4 and MyD88 to mediate protection, but that this protection can be transferred to other
mice without TLR4. The results suggest that protection by EPS does require MyD88 signaling in
myeloid cells, but is not as necessary in peritoneal cells.
The data from the Knight lab suggests that EPS could play a role in the suppression of
inflammation, as in the colitis model used. They have shown that EPS can induce antiinflammatory macrophages, which can be essential for and could alleviate, if not prevent, EAE
[Jones et al., 2014]. Since EAE is an autoimmune disease which causes inflammation of the CNS,
it is possible that these anti-inflammatory macrophages will have an effect on the Th1 and Th17
cells which are thought to be responsible for EAE. We tested this hypothesis and, in preliminary
studies, have seen reduced EAE scores in EPS treated mice. However, further experimentation
is required to confirm our initial observation.
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1.9. Specific aims and significance
1.9.1. Aims
Specific aim 1: Determine which Notch family member is involved in development of EAE by
determining the effect on T helper cell fate.
A. Determine the effects of Notch 3 on Th1 polarization. These experiments were done
by Furkan Ayaz
B. Determine the effects of Notch 3 on Th2 cells by Gata3 levels using flow cytometry
and IL4 and IL5 levels by ELISA.
C. Determine the effects of Notch 3 on Th17 cell polarization by IL17A levels using
ELISA
D. Determine the effects of Notch 3 on iTreg polarization of CD4+CD25- splenic cells to
CD4+CD25+ Treg cells
E. Determine the effects of Notch 3 on nTreg cells by CD4+CD25+ cells in the thymus.
Specific aim 2: Determine whether EPS blocks Th1/Th17 response or expands Treg cells in EAE
inducing conditions.
A. Determine the effect of EPS on in vivo EAE response
B. Identify the cell type that is affected by EPS in EAE response by observation of
cytokines found in infected mice, namely: GM-CSF, IFN-γ, IL-2, and IL-17A.
Note: Much of the studies reported here were done in collaboration with Furkan Ayaz.
Experiments conducted solely by Furkan are noted in the figure legends.

1.9.2. Significance
Multiple Sclerosis (MS) affects millions of people worldwide. The goal of these
experiments is to further understand and make steps towards developing new treatments
based on information from T cell experiments and EPS studies. Notch is known to play a large
role in a number of cells and therefore has been linked to a variety of diseases. Knowing the
role it plays in different cell types, in the context of EAE, could not only help develop therapies
for MS patients, but also help advance our understanding of Notch in other autoimmune
12

diseases, as well as cancers. Based on previous data showing Notch 1 is important in Th1
polarization and not effective in EAE modulation as well as previous data showing Notch 3 to
significantly reduce EAE, we expect to see Notch 3 regulate Th1 and Th17 cells. Based on
preliminary data we expect these experiments to make large strides towards better
understanding the changes caused by Notch 3 in mice immunized with EAE.
EPS has previously been shown to reduce the severity of another inflammatory disease
in immunized mice. It is likely EPS has an effect on cytokine production or translocation of
immune cells to the CNS. We expect a decrease in IL-17A, INF-y, and GM-CSF in in vitro restimulation of immunized T helper cells. These experiments in addition to understanding the
effect EPS has on EAE immunization will help in beginning to develop new treatments as well as
better understanding of the causes of MS, which are currently poorly understood
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CHAPTER 2
RESULTS/DISCUSSION
2.1. Aim 1 results
2.1.1. Aim 1A
We examined the role of Notch 3 on Th1 cell polarization by looking at concentration of
Th1 cytokine, IFN-γ. To achieve this, we looked at IFN-γ levels of CD4+ cells from the spleen of
wild-type (WT) versus Notch 3 heterozygous knockout (N3hetKO) as well as WT versus Notch 3
knockout (N3KO) that have been incubated under Th1 polarizing conditions. We noticed, that
when under Th1 polarizing conditions, there is a significant decrease in IFN-γ levels in both
N3hetKO and N3KO (Figure 3a,c). In addition, we looked at the IL-2 concentration in the same
samples as a control since IL-2 plays an important role in the differentiation and regulation of
CD4+ cells. We noticed that there was virtually no difference in IL-2 concentration (Figure 3b,d)
in either N3hetKO or N3KO samples.
2.1.2. Aim 1B
We hypothesized that Notch 3 may have an effect on Th2 cells. We looked at IL-4 and IL5 concentrations in supernatents after polarizing splenocytes from WT, N3hetKO and N3KO
mice toward the Th2 cell fate. First, in Figure 4a, we looked at polarized versus unpolarized cells
for IL-5 expression. We found there is a difference between WT and N3KO in both polarized and
unpolarized conditions and although not significant, the increase in N3KO Th2 population is
clear. However IL-4 concentrations, as shown in Figure 4b, show no difference between N3KO
and WT in either polarized or unpolarized conditions. In addition, we looked at the expressions
of GATA-3 transcription factor in these conditions. We noticed that N3KO showed a significantly
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lower Gata-3 concentration in both N3KO polarized and unpolarized conditions compared to
the WT (Figure 4c). These data suggest that Notch 3 does not play a critical role in Th2
polarization or Th2 regulation.
2.1.3. Aim 1C
In Figure 5, we examined the effects of Notch 3 on Th17 cells. In order to determine the
effect of Notch 3, we looked at IL-17A as an indicator of Th17 polarization as well as IL-2 as a
control for CD4+ T cell proliferation. In Figure 5a and Figure 5c, we showed that under polarizing
conditions, the absence of Notch 3 significantly reduced concentration of IL-17A. In addition,
we see that Notch 3 has little to no effect on IL-2. Therefore, it is likely that Notch 3 plays a
significant role in Th17 polarization.
2.1.4. Aim 1D
In Figure 6a and 6b, we examined iTreg polarization in WT versus N3hetKO. We analyzed
the difference between both the unpolarized and polarized groups to determine the effects of
Notch3 on iTreg polarization. In order to determine the polarization Tregs, we look at Foxp3,
which is the master regulator of Treg cells as well as CD25, which is found on the surface of
activated T cells and we use to compare activated CD4+Foxp3+ cells to inactive CD4+Foxp3+ cells.
We, therefore, define CD25+Foxp3+ cells as iTregs. Initially, we looked at the CD4+ Foxp3+
population to establish the effect of Notch3 on baseline Foxp3+ cells as a control. However, we
notice in Figure 6a that there is virtually no difference between any of the conditions for the
CD4+ Foxp3+ populations. Next, in Figure 6b, we noticed that unpolarized N3hetKO iTreg
population was significantly higher than the WT. Conversely, when under polarizing conditions,
we noticed that the N3hetKO iTreg population was significantly lower than WT. This data shows
15

that in N3hetKO cells, polarizing cytokines have no effect and the percent of iTreg cells after
polarization remains approximately the same. In contrast, the low levels of iTreg cells in WT
mice are drastically different than the significantly higher percentage of iTreg cells in the
polarized population.
We then looked at the iTreg polarization in WT versus (N3KO) mice. We once again
compared unpolarized versus polarized conditions. In Figure 6c, we look at CD4+Foxp3+ as a
control for FoxP3+ cells and see that although N3KO has slight decrease in CD4+Foxp3+ the
differences are insignificant. Figure 6d shows the iTreg polarization between WT and N3KO.
Similar to N3hetKO, we see a significant decrease in iTreg polarization compared to WT when
under polarizing conditions. The only difference we notice between N3KO and N3hetKO is a
lower percentage of iTreg cells in N3KO compared to WT in non-polarizing conditions.
2.1.5. Aim 1E
In Figure 7 we hoped to examine the effect of Notch 3 on nTreg populations in WT vs
N3KO lymph nodes. These nTreg cells are taken straight from lymph nodes, stained and read by
flow cytometry. Due to the natural polarization of this population, there is no polarization step,
so we only looked at differences between WT vs. N3KO. Figure 7a shows there is a significant
difference in the percentage of nTreg cells present in the lymph node. N3KO mice has a
significantly smaller nTreg cell population compared to WT. Figure7b-7e also shows other
populations of the lymph node, including CD4+Foxp3+, CD4+, CD8+ and CD4+CD8+ cell
populations. These populations show that there is no significant difference in the other major
cell populations in the lymph nodes. This control is done so that we know changes in other
populations are not the cause of the difference in nTreg percentage.
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2.2. Aim 1 discussion
Previous data done by our lab has shown there to be a strong correlation between
Notch 3 and T helper cell types relevant to EAE (Ayaz et al. 2016, Suleiman et al. 2013). We
know the effects of Th1 and Th17 cells have on EAE induction, but we also know that other cells
may play a role, such as iTreg and nTreg cells in the regulation of the other population of T
helper cells and cytotoxic T cell populations. Therefore, in order to study this, we need to look
at Th1, Th17, iTreg and nTreg polarization in Notch 3 knockouts (N3KO) versus wild-type (WT)
mice. It is also important to see the effects on populations we think may not play a large role in
EAE, such as Th2 cells.
Treg polarization is a very interesting target for MS therapy as it targets and regulates
many other cell types. Initially, we wanted to look at the effects of Notch 3 on the inducible
Treg population. What we found was that Treg polarizing conditions in both N3KO and N3hetKO
mice were far less effective than on the WT cells. This observation indicates that Notch 3 plays
a significant and necessary role in the polarization of iTreg cells. In addition, we also
determined that the N3hetKO group displays a significant decrease in the polarization into
iTregs under Treg polarizing conditions. One caveat to the data is the inexplicable increase in
CD25+Foxp3+ cells in the N3hetKO unpolarized condition. However since it is clear that under
polarizing conditions the iTreg population is reduced, we feel confident that Notch 3 influences
iTreg polarization.
Examining the natural Treg population also gives us information on the natural
production of Treg cells in an environment without Notch 3. Since there is no polarization step,
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we only looked at the N3KO versus WT conditions. From this data, we can also say that there is
a significant decrease in the percentage of nTreg in N3KO animals compared to WT. Even
though the total percentage is small, this is approximately the size of the population we would
expect to see for nTreg in the lymph node. In addition, to control for differing cell populations,
we looked at CD4+ and CD8+ as well as double positive populations and noticed no difference in
the numbers, showing us that there is no difference in the overall cell population, such as
higher CD8+ percentage, leading to the lower nTreg population.
We also examined Th2 polarization in WT and N3KO conditions. Since Th2 is not a major
player in MS pathology, we expected there to be either an increase or no difference with lack of
Notch 3, as we expected a decrease of iTreg, Th1 and Th17 polarizations. To this end we
analyzed the concentrations of IL-5 and IL-4 in the supernatants of the cells after polarization.
What we noticed was a clear increase in the concentrations of IL-5. However with IL-4, we saw
no difference at all. This disparity could be for a number of reasons, such as the IL-4 may be
consumed more rapidly than the IL-5 for the polarization of additional Th2 cells. Despite this
disparity, the data suggests that Notch 3 either has no effect or a negative effect on Th2
polarization.
I then looked at Th17 cells and the effect of N3hetKO and N3KO on Th17 polarization.
Since the literature suggests an important role for Notch 3 driving Th17 polarization, we
expected to see a dramatic decrease in IL-17A without Notch 3. With no polarizing cytokines for
both WT and N3hetKO, we see almost no IL-17A at all. When under polarizing conditions, there
is a significant decrease in Th17 polarization (Figure 5). In addition, we see almost the exact
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same results for N3KO as N3hetKO, suggesting hemizygous deletion of Notch 3 is as effective as
homozygous deletion. This data suggests a clear effect of Notch 3 on Th17 polarization.
Finally, I looked at the effect of Notch3 on Th1 polarization. Similar to Th17 polarization,
there was no difference in IFN-γ levels between WT and N3KO or N3hetKO in the unpolarized
conditions (Figure 3). However, there was a significant decrease in IFN-γ concentration in N3KO
and N3hetKO conditions compared to WT, suggesting that Notch 3 plays a critical role in the
polarization of Th1 cells.
Through these experiments, I determined what role Notch 3 plays on the T cells that are
relevant to EAE induction. We determined that Notch 3 plays an important role on polarization
of Th1 and Th17 cells and the lack of Notch 3 resulted in a reduction in the polarization of Th1
and Th17 cells, even in specific polarizing conditions. However, surprisingly Notch 3 also played
a critical role in Treg polarization and natural Treg production. This is unfortunate because since
all three T cells groups are so critically affected by Notch 3, targeting Notch 3 would result in
decreased Th1 and Th17, but also Treg polarization. Although this is not ideal, our data
indicates that Notch 3 could play an important role in EAE and MS therapy, such as Notch 3
blocking antibodies.
2.3. Aim 2 results
2.3.1. Aim 2A
Our preliminary results show a clear difference between EPS treated mice and
untreated EAE induced control. Figure 8 shows that although normal EAE induction reaches a
mean of about three, when treated with EPS, mean disease score is reduced to two.
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We next looked to see if pretreating EAE induction with EPS would have a greater effect
than treating with EPS during induction. The disease scores (Figure 9) showed a similar
significant pattern between normal EAE induction and EAE induction with EPS treatment.
However in mice that were pretreated with EPS on day -3, no signs of disease developed.

2.3.2. Aim 2B
The supernatents from the previous experiment (not shown) have decreased IFN-γ
levels in the EPS treated samples, however no real difference between the levels for IL17A and
GM-CSF were shown between control, EAE induction and EAE induction with EPS treatment.
The ELISAs of the supernatents from the experiment shown in Figure 8 show that there
is a significant decrease in IFN-γ concentration in EPS treated and EPS pretreated, with a slightly
greater decrease in the EPS pretreated (Figure 10). However this is the only similarity to our
preliminary results. We also see in Figure 10 that there is a significant decrease in both GM-CSF
and IL17A and that pretreatment of EPS increases IL17A concentration significantly compared
to regular treatment of EPS.

2.4. Aim 2 discussion
Based on previous data and preliminary results, we thought we would see a significant
decrease in EAE induction consistently as well as an even greater decrease in both the onset of
disease as well as peak score. Our first findings showed a highly significant decrease in score
and a similar pattern in cytokine profile. Initially, we only saw a decrease in IFN-γ levels and
similar levels of IL17A and GM-CSF for EAE induction with or without EPS treatment. However
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upon further investigation, we noticed a significant difference in both GM-CSF and IL17A
concentrations in the supernatents. In addition, we saw a slight increase in concentrations of
both GM-CSF and IL17A when pretreated with EPS compared to regular EPS treatment. This
disparity could be due to the pretreatment preventing disease earlier and by the time point of
peak disease for normal EAE induction, the mouse could be already returning to homeostasis.
However, since the difference isn’t significant, it is also very likely that there is actually no
difference and the disparity is just coincidence.
Due to technical problems with EPS purity and EAE induction the experiment could not
be replicated. However there is clearly enough evidence here to continue this experiment and
try to confirm the results shown in Figures 7-9.

2.5. Summary/future directions
Based on outside data as well as preliminary results by other members of the Osborne
lab, I was interested in seeing the effects of Notch 3 on T helper cell fate and the effects that it
could have on the mouse model of MS, EAE, as well as the effects of EPS on specific cell fates in
respect to EAE. In collaboration with Furkan Ayaz, I looked at the effects of Notch 3 on Th1, Th2,
Th17, and iTreg induction in vitro using Notch 3 knockouts and wild-type mice as a control. My
results were obtained by looking at the cell populations by flow cytometry, as was the case for
iTreg polarization, as well as by ELISA assay of premier cytokines for each cell type, such as IFNγ for Th1, IL-4 and IL-5 for Th2, and IL17A for Th17 cells.
I first began by looking at Treg polarization, both nTreg and iTreg. In these experiments,
I was able to determine that Notch 3 had no significant effect on the total CD4+ T cell
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population (Figure 6a, c and Figure 7b). There is a clear difference in the heterozygous Notch 3
knockout with unpolarized cells having a significantly highly portion of Tregs. However under
polarizing conditions, there are a significantly smaller percentage of CD25+Foxp3+ cells. In Notch
3 knockouts however, we see no difference in the unpolarized cells, and a greater decrease in
the Notch 3 knockout polarized group versus the polarized wild-type control group. We then
looked at nTreg cells which occur naturally in the thymus and discovered that there was a
significant decrease in Notch 3 knockout mice compared to the wild-type. I also found a very
similar decrease in Th17 and Th1 polarized cells with Notch 3 knocked-out. With Th2, we saw a
significant increase in Th2 polarization compared to wild-type when under polarizing
conditions. These data point to a significant role that Notch 3 plays in the polarization of Th1,
Th17 and Treg cells. Although this may not be a possible target for treatment of MS by itself
due to the effect on Treg cells, it is possible that in conjunction with another treatment that
may boost regulatory T cell production, this could be a very viable target as the lack of Notch 3
greatly reduces both Th1 and Th17 cells. It will also be important in the future to see what
effects Notch 3 has directly on EAE induction and what the cytokine profile of Notch 3 knockout
mice is after EAE induction.
From experiments done by our collaborator, Katherine Knight, as well as previous data,
we have determined that EPS could be a treatment for EAE. It is unclear how EPS may protect
mice from EAE induction. However it is thought that EPS may induce anti-inflammatory
macrophages, which have been shown to reduce EAE disease scores. Through our experiment,
it is clear that EPS could significantly reduce EAE through reduction of Th1, Th17 and GM-CSF
producing T cells. Not much is known about how EPS could confer protection against these
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inflammatory diseases, but there is clear evidence that EPS reduces disease peak and affects
onset of severe symptoms. In addition, mice pretreated with EPS develop no symptoms of the
disease at all and both pretreated and regularly treated mice have far lower concentrations of
IFN-γ, GM-CSF, and IL17A in the supernatents of the splenocytes treated with MOG. Based on
these results, we can say that it is likely EPS somehow decreases the polarization of Th1 and
Th17 cells or Th1 and Th17 cytokine production, which greatly reduces disease onset of EAE.
These experiments need to be replicated and further study needs to go into the method by
which EPS reduces disease. The pathway by which EPS functions could make it clearer as to how
disease is being protected and to the means by which prevention occurs and can be used for
medical uses. Despite the drawbacks, this data is very promising and if it can be replicated, it
could be a very big leap for MS research and treatment.
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CHAPTER 3
MATERIALS AND METHODS
3.1. Mice
C57BL/6 and Notch3 knockout mice were purchased from Jackson Laboratory and bred
in our mouse facilities and were used for CD4+ T cell polarizations. C57BL/6 mice were
purchased from Taconic and used for EAE induction experiments. Mice used for experiments
were ages 10-13 weeks old. All mice were housed at animal facilities according to guidelines of
Institutional Animal Care and Use Committee at University of Massachusetts – Amherst. In
order to, control the influence of microbiota on the induction of EAE cage beddings with
excretions were exchanged between knockout and wild type control mice cages at least for one
week while housing in the same animal facility.

3.2. CD4+ T cell in vitro polarizations
CD4+ T cells are isolated from splenocytes using Anti-CD4 magnetic beads (BD
Pharmingen). Cells are plated on a 12 well plate coated with 1ug/ml of anti-CD3 (BD
Pharmingen) and 1ug/ml of anti-CD28 (BD pharmingen) at a concentration of 3x106 cells/ml.
Th1 polarization is done by adding 10ug/ml of anti-IL-4 and 1ng/ml recombinant mouse IL-12
(BD Pharmingen) into the culture media. Th2 polarization is done by adding 10ug/ml of antiIFNγ and 1ng/ml recombinant mouse IL4 (BD Pharmingen) into the culture media. Th17
polarization is done by adding 10ug/ml of anti-IL4, 10ug/ml of anti-IFNγ (BD Pharmingen),
20ng/ml IL6 and 5ng/ml TGFβ1 (R&D systems) into the culture media (In some conditions
5ng/ml IL23 was also added into culture media (R&D systems)). For iTreg polarization
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CD4+CD25-cells from bulk splenocytes are enriched by CD4 T cell enrichment set with 2.5ug
biotin conjugated anti-CD25 (BD Pharmingen). Cells are activated in the presence of 2ng/ml of
TGFβ1 (R&D systems). nTreg levels are measured in the thymus of mice by isolating the
thymocytes and then doing CD25 surface and Foxp3 intracellular staining. CD4, CD8, CD25, and
CD69 surface staining as well as Foxp3 intracellular staining are done at 72 hour time point of
cell activation and cells are analyzed on a FACS LSRII (Becton Dickinson). The media used, RDGS,
consists of half and half mixture of RPMI and DMEM (LONZA) with 10% Fetal Bovine Serum
(GIBCO), 5% L-Glutamine, 5% Na-Pyruvate, 5% Penicillin/Streptomycin (LONZA) and 0.1% βmercaptoethanol. After 72h of polarization incubation, cytokine levels in the supernatants are
determined by an ELISA assay (BD Pharmingen). All antibodies are purchased from eBioscience
and intracellular staining for Foxp3 is done by following the instructions on eBioscience Foxp3
intracellular staining kit.

3.3 EAE induction and re-stimulation
This protocol is described in the Hooke’s Kit (EK-2110) and is done on female C57BL/6
mice aged 10+ weeks. Mice are injected subcutaneously on the flank with MOG35-55/CFA
Emulsion. After 2 hours and 24 hours from MOG35-55 injection, pertussis toxin is injected
intraperitoneally. Pertussis toxin was dissolved in PBS and injected at a concentration of 2ug/ml
at 100 ul/injection. Disease onset is approximately 9-14 days after initial immunization. Disease
progression is scored on a scale from 0-5 as such: 0-no signs of disease, 1- completely limp tail,
2- weakness and mild paralysis of hind legs, 3- Paralysis of hind legs and torso flattening, 4Complete paralysis of hind and fore limbs and full torso flattening, 5- Death. At peak disease at
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day 15, mice are sacrificed and splenocytes are isolated from spleens of EAE induced mice for
re-stimulation. Splenocytes are plated in RDGS for 5 days at a concentration of 5x10 6 cells/ml in
the presence of MOG35-55 antigen (Hooke’s kit DS-0111) at 0, 10 and 20ug/ml concentrations.
After 5 days, supernatents are collected from cultures for analysis of IFN-γ , GM-CSF and IL-17A
cytokines by ELISA.

3.4. EAE adoptive transfer
Adoptive transfer protocol follows the same EAE induction stated above for donor mice.
Due to the unpredictability of harvesting splenocytes, two donor mice were often used per
recipient mouse. After induction of EAE in donor mice and isolation of splenocytes, cells were
plated on round tissue culture dishes at a concentration of 3x10 6 cells/ml at 10 mls per dish.
Cells were plated in RDGS in the presence of 20 ug/ml of MOG35-55 antigen (Hooke’s kit DS0111) and 20 ng/ml IL-23 (R&D systems) and incubated for 72 hours. After 72 hours, cells were
harvested and resuspended in sterile PBS at a concentration of 4x107 cells/ml. Recipient mice
were then injection intraperitoneally with 1 ml of cells followed by intraperitoneal injection of
pertussis toxin at 2hrs and 24hrs after induction. In addition, i.v. injections are also possible and
done injecting half the concentration of cells into recipient mice (2x107 cells/ml).

3.5. ELISA
Cytokine secretion was measured in supernatants following incubation for polarization
experiments and following restimulation for EAE experiments. Concentration of IFN-γ, IL-2, IL-4,
IL-5, IL-17A, and GM-CSF were measured using antibodies described below in a sandwich ELSIA.
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96 well flat-bottom plates were coated with capture antibody as instructed by supplier
and incubated at 4°C overnight. Following day, coating was removed and plates were washed
with PBS-T (0.05% Tween-20). Plates were then blocked for 2 hours in 200ul/well of 5% non-fat
dry milk in PBS at room temperature. Plates were washed again using PBS-T and samples were
added 100ul/well. Samples were diluted based on previous results such that the resulting
concentrations fell within the range of detection. Samples were incubated at 4°C overnight.
The following day, plates were washed again with PBS-T. Plates were then coated with Avidin
Horseradish Peroxidase (HRP) for 2 hours at room temperature. Following another wash in PBST, plates were coated with matching biotinylated antibody (listed below) for 1 hour. Plates were
then washed again with PBS-T followed by PBS. Plates were then read on a plate reader at
450nm and analyzed.

3.6. Flow cytometry
A Becton Dickinson LSR II was used for Flow Analysis. Samples were stained for CD4,
CD8a, CD25, and intracellular Foxp3.
Cells were collected from plate and supernatents were removes. Cells were extracellularly
stained in 50 ul of PBS with 2% BSA at 4°C for 30 minutes. After removing staining, cells that
were to be intracellularly stained for Foxp3 were plating in 200 ul of fixation/permeabilization
buffer (listed below) for 30 minutes at 4°C. After decanting supernatant, plates were coated in
50ul/well of permeabilization buffer and 2 ul of rat anti-mouse Foxp3 and incubated in 4°C for
30 minutes. Supernatents were then decanted again and cells were removed into FACS tubes,
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resuspended in perm buffer and read on the LSR II. Cells not requiring intracellular staining
were resuspended in perm buffer after extracellular staining was complete and read on LSR II.

3.7. Statistical analysis
Graphpad Prism Software (v. 5) is used to perform statistical analysis of data from ELISA
assay, specifically unpaired two tailed t-test for cell polarizations. In addition, FlowJo (v. 7.6.5) is
used for analysis of data collected from flow cytometry. P > 0.05 is considered significant.
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Table 1. Reagent for ELISAs, Antibodies and Growth Factors Used
Reagent Name

Vendor

Catalog Number

Mouse CD4 T Lymphocyte

BD Imag

558131

Recombinant Human TGF-β1

R and D Systems

240-B-002

Recombinant Mouse GMCSF

eBioscience

14-8331

Recombinant Mouse IL2

BD Pharmingen

550069

Recombinant Mouse IL3

R and D Systems

403-ML-010

Recombinant Mouse IL4

R and D Systems

404-ML-010

Recombinant Mouse IL6

R and D Systems

406-ML-005/CF

Recombinant Mouse IL23

R and D Systems

1887-ML-010

Avidin Horseradish Peroxidase

BD Pharmingen

554058

Purified Rat Anti mouse IFNγ

BD Pharmingen

554409

Biotin Rat Anti-mouse IFNγ

BD Pharmingen

554410

Purified Rat Anti-mouse IL-2

BD Pharmingen

554424

Biotin Rat Anti-mouse IL-2

BD Pharmingen

554426

Purified Rat Anti-mouse IL-4

BD Pharmingen

559062

Biotin Rat Anti-mouse IL-4

BD Pharmingen

554390

Purified Rat Anti-mouse IL-5
Clone: TRFK5

eBioscience

14-7052-85

Enrichment Set-DM

(HRP)
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Biotin Rat Anti-mouse IL-5

eBioscience

13-7051-85

Purified Rat Anti-mouse IL17A

BD Pharmingen

555068

Biotin Rat Anti-mouse IL17A

BD Pharmingen

555067

Purified Rat Anti-mouse GMCSF

eBioscience

14-7331-81

eBioscience

13-7332-81

BD Pharmingen

551539

BD Pharmingen

553049

BD Pharmingen

553052

eBioscience

25-0081-82

BD Pharmingen

557192

Clone: TRFK5

Clone: MP1-22E9
Biotin Rat Anti-mouse GMCSF
Clone: Mp1-3166
Anti-mouse CD4 Magnetic
Particles DM
PE Rat Anti-mouse CD4
Clone: RM4-5
PerCP Rat Anti-mouse CD4
Clone: RM4-5
PE-Cy7 Rat Anti-mouse CD8a
Clone: 53-6.7
APC Rat Anti-mouse CD25
Clone: PC61
PE Rat Anti-mouse Foxp3 Clone: eBioscience
FJK-16s

12-5773-82

Foxp3 Staining Buffer Set

00-5523-00

eBioscience
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Figure 1: Structure of Notch family members. Notch 1, 2, 3 and 4 all have minor differences
that vary between the number of EGF-like repeats, to the presence of a transcriptional
activation domain. These differences change the behavior and function of each of the Notch
members. Specifically Notch 3 has fewer EGF-like repeats than Notch 1 and 2 and does not
have a transcription activation domain. Image from: Trojantec. 2007-2012.
http://trojantec.com/site.80.articles.en.html.
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Figure 2: Multiple Sclerosis function and overview. Demyelination occurs by the activation
and immunization of cells by myelin and neural degeneration of myelin sheaths of nerve cells.
Repair of these cells is possible by oligodendrocytes (not shown) however multiple sclerosis
prevents production of these cells. In addition Treg cells can promote self-tolerance but are
also prevented by the activation of Th1 and Th17 cells. Image from: Metcalfe, Su M. (2011).
Multiple sclerosis: One protein, two healing properties, Nature, 477, 287–288.
doi:10.1038/477287a
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b)

N3KO
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Figure 3: Absence of Notch 3 results in decreased IFN-γ levels in cells polarized toward Th1
cell fate from CD4+ splenocytes. CD4+ splenocytes were isolated from wild-type (WT),
heterozygous Notch 3 knockout (N3hetKO), and Notch 3 knockout mice (N3KO). Cells were
plated in polarizing conditions for 72 hours, harvested and supernatents were analyzed by
ELISA for IFN-γ (IFNg on axis). Conditions for both experiments include an unpolarized control
group (NP), which was plated without any supplemental polarizing cytokines, and a Th1
polarized group which was plated with anti-IL-4 as well as recombinant IL-12. (a,d) IL-2 was
used as a proliferation control and the ELISAs are shown. (b,c) Concentration of IFN-γ was
used to determine Th1 polarization. Data represents the mean ± SEM, *p < 0.05,

**p < 0.005, ***p < 0.001
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Figure 4: Notch 3 knockouts decrease expression of Gata 3 as well as increase IL-5
concentration without having an effect on IL-4. CD4+ splenocytes were isolated from wildtype (WT) and Notch 3 knockout (N3KO) mice. Cells were isolated, incubated under polarizing
conditions for 72 hours, harvested and then analyzed by ELISA. Conditions in which cells were
played include an unpolarized control group (UP), which contained no supplemental polarizing
cytokines, and a Th2 polarized group which was supplemented with anti-IFN-γ and IL-4. (a) IL-5
ELISA (b) results of IL-4 ELISA and (c) results of Gata-3 flow cytometry were done to determine
effects on Th2 polarization. Data represents the mean ± SEM, *p < 0.05, **p < 0.005,

***p < 0.001
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N3KO
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Figure 5: Absence of Notch 3 results in decreased IL-17A levels in cells polarized toward Th17
cell fate from CD4+ splenocytes. CD4+ splenocytes were isolated from wild-type (WT),
heterozygous Notch 3 knockout (N3hetKO), and Notch 3 knockout mice (N3KO). Cells were
plated in polarizing conditions for 72 hours, harvested and supernatents were analyzed by
ELISA for IL-17A. Conditions for both experiments include an unpolarized control group (NP),
which was plated without any supplemental polarizing cytokines, and a Th17 polarized group
which was plated with anti-IFNγ, anti-IL4, recombinant IL6 and recombinant TGFβ1. (a,d) IL-2
was used as a proliferation control and the ELISAs are shown. (b,c) Concentration of IL-17A
was used to determine Th17 polarization. Data represents the mean ± SEM, *p < 0.05,

**p < 0.005, ***p < 0.001
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Figure 6: Absence of Notch 3 reduces polarization of cells toward induced Treg cell fate.
CD4+CD25- cells were isolated from the spleens of Wild-Type (WT), Notch 3 heterozygous
knockout (N3HetKO) and Notch 3 knockout (N3KO) mice. Cells were then either plated with no
supplemental cytokines (unpolarized) or were activated using iTreg polarizing cytokines (TGFβ1)
for 72 hours. Groups were then stained for CD4, CD25 and intracellularly stained for Foxp3 and
then analyzed by flow cytometry. (a,c) Control group showing the percentage of CD4+ Foxp3+
cells before and after polarization. (b,d) Experimental group showing the percentage of CD25+
Foxp3+ before and after polarization. Data represents the mean ± SEM, *p < 0.05,

**p < 0.005, ***p < 0.001
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Figure 7: Absence of Notch 3 reduces the
percent of natural Tregs found in lymph nodes.
Cells were isolated from the lymph nodes of WildType (WT) and Notch 3 knockout (N3KO) mice.
Cells are isolated, stained for CD4, Cd8, Cd25 and
intracellular Foxp3 and then analyzed by flow
cytometry. (a) nTreg (CD25+Foxp3+) population.
(b) control (CD4+Foxp3+) population (c) CD4+
control population. (d) CD8+ control population.
(e) CD4+ CD8+ control population. Data
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Figure 8: Preliminary EAE induction with EPS treatment of WT mice done by Furkan Ayaz. The
EPS treatment was done at day 0, and disease score was noticed on a scale of 1-5 up to day
14. Data represents the mean ± SEM, *p < 0.05, **p < 0.005, ***p < 0.001
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Figure 9: Administration of EPS during EAE induction significantly reduces EAE severity and
administration before EAE induction reduces EAE severity to zero. Mice were either treated
with just PBS (EAE induced), with EPS at day 0 (EAE induced + EPS), or with EPS at day -3 (EAE
induced + pretreated EPS) from disease induction. Disease score was determined on a scale of
1-5 and presented here. N=4 for each group. Data represents the mean ± SEM, *p < 0.05,

**p < 0.005, ***p < 0.001
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b)

a)
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Figure 10: EPS treated samples all significantly lower concentrations of IFN-γ, IL17A and
GMCSF compared to control. PBS treated vs EPS treated (EPS) and EPS pretreated (PRE EPS)
samples were compared. After EAE induction (described in methods) splenocytes were
isolated and incubated for 120 hours with different concentrations of MOG peptide (0, 5, 10,
and 20 ug/ml). ELISAs were done for (a) IFNy, (b) IL17A, and (c) GM-CSF.
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